| Literature DB >> 29634950 |
Jianfeng Huang1, Angeles Duran1, Miguel Reina-Campos2, Tania Valencia1, Elias A Castilla1, Timo D Müller3, Matthias H Tschöp3, Jorge Moscat4, Maria T Diaz-Meco5.
Abstract
Obesity is a leading risk factor for cancer. However, understanding the crosstalk between adipocytes and tumor cells in vivo, independently of dietary contributions, is a major gap in the field. Here we used a prostate cancer (PCa) mouse model in which the signaling adaptor p62/Sqstm1 is selectively inactivated in adipocytes. p62 loss in adipocytes results in increased osteopontin secretion, which mediates tumor fatty acid oxidation and invasion, leading to aggressive metastatic PCa in vivo. Furthermore, p62 deficiency triggers in adipocytes a general shutdown of energy-utilizing pathways through mTORC1 inhibition, which supports nutrient availability for cancer cells. This reveals a central role of adipocyte's p62 in the symbiotic adipose tissue-tumor collaboration that enables cancer metabolic fitness.Entities:
Keywords: CPT1; adipocyte; cancer; fatty acid oxidation; metabolic reprogramming; obesity; osteopontin; p62; prostate; sequestosome-1
Mesh:
Substances:
Year: 2018 PMID: 29634950 PMCID: PMC5896786 DOI: 10.1016/j.ccell.2018.03.001
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743